TABLE 3.

Average baseline for cardiovascular and blood glucose measures.

	HR (BPM) day 1	HR (BPM) day 7	MAP (mmHg) day 1	MAP (mmHg) day 7	BGL (mmol/L) day 1	BGL (mmol/L) day 7
Caffeine capsule	63.25 ± 10.2	59.87 ± 7.4	85.26 ± 9.8	89.61 ± 9.5	4.25 ± 0.24	4.13 ± 0.32
C. annuum fruit capsule	58.12 ± 8.6	58.34 ± 6.9	89.8 ± 8.4	85.42 ± 3.6	4.53 ± 0.16	4.41 ± 0.28
Placebo capsule	66.13 ± 8.4	67.31 ± 8.6	88.53 ± 6.5	90.73 ± 6.1	4.42 ± 0.24	4.38 ± 0.18
p value	0.25	0.09	0.92	0.82	0.07	0.22

Average baseline for cardiovascular and blood glucose measures prior to supplementation. Statistical testing indicates no difference in baseline conditions prior to interventions. p value is calculated using a one-way ANOVA, Welch’s correction, n = 8 per intervention. Values are means ± SD (n = 8 per intervention). HR, heart rate (beats per minute); MAP, mean arterial pressure (millimetres of Mercury); BGL, blood glucose levels (millimole per litre).